A case of thrombotic thrombocytopenic purpura in a patient with a recent flare of cerebral lupus is presented. The patient presented with neurologic symptoms, pyrexia, thrombocytopenia and leucocytosis. 
A case of thrombotic thrombocytopenic purpura in a patient with a recent flare of cerebral lupus is presented. The patient presented with neurologic symptoms, pyrexia, thrombocytopenia and leucocytosis. Following initial investigation, imaging of brain and negative microbiology, a diagnosis of cerebral lupus was made and appropriately treated. After a stable period of two weeks, deterioration in clinical status, haematology and renal indices, a diagnosis of thrombotic thrombocytopenic purpura (TTP) was made and treated. The two diagnoses presenting together are briefly discussed. CASE REPORT: A 74-year-old Caucasian lady presented with a 3-day history of headache, drowsiness, vomiting and generalised aches and pains. She had a 2-year history of systemic lupus erythematosus (SLE). Her 4 .9mmol/L. CSF culture was negative including acid fast fungal and viral cultures. PCR and antigen levels for meningococcus were negative. The patient developed an absence seizure with transient right-sided weakness followed by a focal seizure progressing to a generalised tonic-clonic seizure. Glasgow Coma Scale (GCS) post seizure was 9/15. Her GCS improved; however the patient remained confused and cognitively impaired, with brisk reflexes and an extensor left plantar reflex. Magnetic resonance imaging (MRI) of brain revealed mild to moderate degree of cerebral parenchymal loss. Wide scattered ill-defined high signal intensity was noted in the white matter, which was thought to represent gliotic ischaemic changes.
TTP in SLE
A clinical diagnosis of cerebral lupus was made. The patient was given intravenous methylprednisolone, Ig for 3 consecutive days, then commenced on oral prednisolone daily and she received pulse cyclophosphamide 500mg intravenously weekly. There was an improvement in her cognitive impairment and clinical condition. After a stable period of two weeks, her clinical condition declined with deterioration in cognitive function. Her platelet count fell to 41 x 109/l and Hb to 7.4g/dl, (normal MCV and MCH). On 24 hour urine collection she had 1.1 3g proteinuria. Total bilirubin and lactate dehydrogenase were mildly elevated. Direct Coombs test was negative. Reticulocyte count was 3.5%. Prothrombin time and fibrinogen were normal. Blood film revealed fragmented red blood cells. Bone marrow aspirate did not detect a monoclonal T-cell or B-cell population. There were some megakaryocytes present but they were not particularly plentiful. Some histiocytes were also present. On peripheral blood analysis there was no evidence of platelet associated immunoglobulin detected by flow cytometry. arthritis. When the disease is active there can be immunologic abnormalities: marked inflammatory response; low levels of serum complement; and elevation of anti-nuclear antibodies. Risk factors for the development of CNS disease in a lupus patient are not clearly defined. One study by Karassa et all tried to define these risks. In the study the most frequent neuropsychiatric SLE (NPSLE) syndromes were cerebrovascular disease (28%), seizures (25%), acute confusional states (19%), and psychosis (9%). 3-8% of patients presented with a combination of two or more symptoms. It was suggested that vasculitis, thrombocytopenia and anti-phospholipid syndrome features correlated with CNS involvement. It was negatively associated with articular features and discoid rash. Normal levels of dsDNA were also seen in active CNS disease, but anti La antibodies as well as low level of complements especially C4 were seemingly strongly associated with NPSLE. TTP has rarely been seen in association with SLE, but is recognised in the literature and the two disease processes were first described together in 1939. The ability to diagnose TTP as a separate process, in the setting of SLE is challenging, as TTP has no specific diagnostic test and also because TTP shares, in common with SLE, clinical signs and features such as fever, renal abnormalities, neurological deficit, thrombocytopenia, and haemolytic anaemia. 
